These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 33340991)
41. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Hahm K; Lukashev ME; Luo Y; Yang WJ; Dolinski BM; Weinreb PH; Simon KJ; Chun Wang L; Leone DR; Lobb RR; McCrann DJ; Allaire NE; Horan GS; Fogo A; Kalluri R; Shield CF; Sheppard D; Gardner HA; Violette SM Am J Pathol; 2007 Jan; 170(1):110-25. PubMed ID: 17200187 [TBL] [Abstract][Full Text] [Related]
42. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice. Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894 [TBL] [Abstract][Full Text] [Related]
43. A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer. Liu J; Chiang HC; Xiong W; Laurent V; Griffiths SC; Dülfer J; Deng H; Sun X; Yin YW; Li W; Audoly LP; An Z; Schürpf T; Li R; Zhang N J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37328286 [TBL] [Abstract][Full Text] [Related]
44. CD36 Promotes Podocyte Apoptosis by Activating the Pyrin Domain-Containing-3 (NLRP3) Inflammasome in Primary Nephrotic Syndrome. Yang X; Wu Y; Li Q; Zhang G; Wang M; Yang H; Li Q Med Sci Monit; 2018 Sep; 24():6832-6839. PubMed ID: 30258045 [TBL] [Abstract][Full Text] [Related]
45. Two-step release of kinase autoinhibition in discoidin domain receptor 1. Sammon D; Hohenester E; Leitinger B Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22051-22060. PubMed ID: 32839343 [TBL] [Abstract][Full Text] [Related]
46. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Cosgrove D; Rodgers K; Meehan D; Miller C; Bovard K; Gilroy A; Gardner H; Kotelianski V; Gotwals P; Amatucci A; Kalluri R Am J Pathol; 2000 Nov; 157(5):1649-59. PubMed ID: 11073824 [TBL] [Abstract][Full Text] [Related]
47. Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss. Ryu M; Kulkarni OP; Radomska E; Miosge N; Gross O; Anders HJ Kidney Int; 2011 Jan; 79(2):189-98. PubMed ID: 20962742 [TBL] [Abstract][Full Text] [Related]
48. Collagen induces activation of DDR1 through lateral dimer association and phosphorylation between dimers. Juskaite V; Corcoran DS; Leitinger B Elife; 2017 Jun; 6():. PubMed ID: 28590245 [TBL] [Abstract][Full Text] [Related]
49. Chemical chaperones to the rescue of Alport syndrome? Vanacore RM Kidney Int; 2024 Sep; 106(3):359-361. PubMed ID: 39174196 [TBL] [Abstract][Full Text] [Related]
50. Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Franco C; Ahmad PJ; Hou G; Wong E; Bendeck MP Circ Res; 2010 Jun; 106(11):1775-83. PubMed ID: 20448217 [TBL] [Abstract][Full Text] [Related]
51. Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1. Huang H; Svoboda RA; Lazenby AJ; Saowapa J; Chaika N; Ding K; Wheelock MJ; Johnson KR J Biol Chem; 2016 Oct; 291(44):23208-23223. PubMed ID: 27605668 [TBL] [Abstract][Full Text] [Related]
52. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. Avivi-Green C; Singal M; Vogel WF Am J Respir Crit Care Med; 2006 Aug; 174(4):420-7. PubMed ID: 16690978 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of DDR1 reduces invasive features of human A375 melanoma, HT29 colon carcinoma and SK-HEP hepatoma cells. Romayor I; Badiola I; Olaso E Cell Adh Migr; 2020 Dec; 14(1):69-81. PubMed ID: 32090682 [TBL] [Abstract][Full Text] [Related]
54. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Franco C; Hou G; Ahmad PJ; Fu EY; Koh L; Vogel WF; Bendeck MP Circ Res; 2008 May; 102(10):1202-11. PubMed ID: 18451340 [TBL] [Abstract][Full Text] [Related]
55. Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome. Liu X; Ducasa GM; Mallela SK; Kim JJ; Molina J; Mitrofanova A; Wilbon SS; Ge M; Fontanella A; Pedigo C; Santos JV; Nelson RG; Drexler Y; Contreras G; Al-Ali H; Merscher S; Fornoni A Kidney Int; 2020 Nov; 98(5):1275-1285. PubMed ID: 32739420 [TBL] [Abstract][Full Text] [Related]
56. Albumin contributes to kidney disease progression in Alport syndrome. Jarad G; Knutsen RH; Mecham RP; Miner JH Am J Physiol Renal Physiol; 2016 Jul; 311(1):F120-30. PubMed ID: 27147675 [TBL] [Abstract][Full Text] [Related]
57. Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma. Hur H; Ham IH; Lee D; Jin H; Aguilera KY; Oh HJ; Han SU; Kwon JE; Kim YB; Ding K; Brekken RA BMC Cancer; 2017 Jan; 17(1):87. PubMed ID: 28143619 [TBL] [Abstract][Full Text] [Related]
58. Two Specific Sulfatide Species Are Dysregulated during Renal Development in a Mouse Model of Alport Syndrome. Gessel MM; Spraggins JM; Voziyan PA; Abrahamson DR; Caprioli RM; Hudson BG Lipids; 2019 Jun; 54(6-7):411-418. PubMed ID: 31197846 [TBL] [Abstract][Full Text] [Related]
59. Novel Therapies for Alport Syndrome. Chavez E; Rodriguez J; Drexler Y; Fornoni A Front Med (Lausanne); 2022; 9():848389. PubMed ID: 35547199 [TBL] [Abstract][Full Text] [Related]
60. Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease. Soomro I; Hong A; Li Z; Duncan JS; Skolnik EY PLoS One; 2019; 14(7):e0211670. PubMed ID: 31260458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]